share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

SEC announcement ·  Feb 22 04:11
Summary by Futu AI
Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], was involved in a transaction with the company's stock on January 23, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within the company.
Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], was involved in a transaction with the company's stock on January 23, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within the company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.